Delenex Therapeutics

Delenex Therapeutics AG is a Swiss biotechnology company dedicated to developing therapeutic antibody fragments targeting severe medical conditions with high demand. The company's fragments are designed for local/topical application, leveraging the benefits of antibody therapies with only limited systemic exposure. Its clinically validated technology delivers antibodies with the highest affinity, solubility, and stability while posing an extremely low risk of immunogenicity.